SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-004372
Filing Date
2022-03-25
Accepted
2022-03-25 17:50:38
Documents
1
Period of Report
2022-03-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-55853.html 4  
1 PRIMARY DOCUMENT marketforms-55853.xml 4 3994
  Complete submission text file 0001214659-22-004372.txt   5387
Mailing Address UCLA SCHOOL OF MEDICINE 10833 LE CONTE 66-118 CHS BOX 951738 LOS ANGELES CA 9095-1738
Business Address
Belldegrun Arie (Reporting) CIK: 0001296549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 22772694

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences